Evidence map›Paper›PMID 41981532›Full record

ArticleBMC musculoskeletal disorders2026

Effectiveness of preoperative intravenous tranexamic acid on reduction of perioperative blood loss in open intramedullary nail fixation of femoral shaft fractures in a tertiary hospital, Uganda: a prospective cohort study.

Paul Kaweesa Kabazzi, Patrick Sekimpi, Edward Kironde, Yakobo Nsubuga, Esther Mirembe

Registry-linked trialAbstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07261930 (Effectiveness of Preoperative Intravenous Tranexemic Acid on Reduction of Perioperative Blood Loss in Open Intramedullary Nail Fixation of Femoral Shaft Fractures in Mulago), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07261930 phase4completednot on this map

Effectiveness of Preoperative Intravenous Tranexemic Acid on Reduction of Perioperative Blood Loss in Open Intramedullary Nail Fixation of Femoral Shaft Fractures in Mulago

TypeinterventionalSponsorMasaka Regional Referral HospitalRan2018 to 2019Enrolled43ConditionsFemoral Fractures, Hemorrhage, Surgical, Tranexamic Acid UseArmsTranexamic Acid
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paul Kaweesa KabazziDepartment of Orthopedic Surgery, Masaka Regional Referral Hospital, Masaka, Uganda. kabazzip@gmail.com.
Patrick SekimpiDepartment of Orthopedic Surgery, Mulago National Referral Hospital, Kampala, Uganda.
Edward KirondeDepartment of Orthopedic Surgery, Mulago National Referral Hospital, Kampala, Uganda.
Yakobo NsubugaDepartment of Orthopedic Surgery, Mulago National Referral Hospital, Kampala, Uganda.ORCID http://orcid.org/0000-0001-5592-732X
Esther MirembeDepartment of Research and Data, SEMA, Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOpen intramedullary nailing of femoral shaft fractures (OIN) is frequently performed in low-resource settings where limited access to fluoroscopy necessitates open reduction techniques associated with substantial perioperative blood loss. In environments where blood supply is constrained and transfusion carries additional risks, strategies to minimize bleeding are critical. Tranexamic acid reduces perioperative bleeding in multiple orthopaedic procedures; however, evidence supporting its use during OIN in low- and middle-income countries remains limited.

methodsWe conducted an open-label, single-arm prospective cohort study at a tertiary hospital in Uganda between December 2018 and March 2019. Adult patients undergoing OIN received a single preoperative intravenous dose of tranexamic acid (15 mg/kg). Perioperative blood loss was assessed using change in haemoglobin concentration measured preoperatively and at 72 h postoperatively, and compared with a historical institutional mean from patients managed without tranexamic acid. Secondary outcomes included blood transfusion requirements and adverse events.

resultsForty-three patients were included. The mean perioperative haemoglobin decline was 1.7 g/dL. This observed decline was lower than the historical mean of 3.31 g/dL reported in cohorts managed without tranexamic acid, corresponding to a mean difference of 1.6 g/dL (p < 0.001). Two patients (4.7%) required intraoperative blood transfusion, each receiving one unit of whole blood. No postoperative transfusions were administered. Minor adverse events were infrequent, and no clinically apparent thromboembolic events were identified during the follow-up period.

conclusionsPreoperative intravenous tranexamic acid was associated with reduced perioperative blood loss and low transfusion requirements during OIN in this resource-limited setting. Controlled studies are needed to confirm these findings.

trial registrationClinicalTrials.gov NCT07261930. Retrospectively registered on 21 July 2025.

Indexed as

Antifibrinolytic AgentsBlood Loss, SurgicalFemoral FracturesFracture Fixation, IntramedullaryTranexamic AcidAdministration, IntravenousAdultBlood TransfusionFemaleHumansMaleMiddle AgedPreoperative CareProspective StudiesTertiary Care CentersTreatment OutcomeAntifibrinolytic AgentsTranexamic AcidFemoral Shaft FracturesOpen Intramedullary NailingPerioperative Blood LossResource-limited SettingsTranexamic Acid

Identifiers

PMID41981532
PMCPMC13195939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.